Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer

Breast cancer (BC) is still the most common cancer among women worldwide. Amongst the subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient expression of estrogen, progesterone, and human epidermal growth factor receptor 2 receptors. These patients are therefore not give...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakhjavani, Maryam, Hardingham, Jennifer E, Palethorpe, Helen M, Price, Tim J, Townsend, Amanda R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769384/
https://www.ncbi.nlm.nih.gov/pubmed/31598336
http://dx.doi.org/10.4048/jbc.2019.22.e39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769384/
https://www.ncbi.nlm.nih.gov/pubmed/31598336
http://dx.doi.org/10.4048/jbc.2019.22.e39

Ejemplares similares